Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
10:31am, Monday, 21'st Aug 2023
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Is Amgen Stock a Top Buy and Hold?
08:15am, Monday, 21'st Aug 2023
Buying and holding stocks for long periods of time can generate market-beating results. Most individual stocks, however, aren't capable of delivering above-average results over the long haul.
Could Amgen Stock Help You Become a Millionaire?
10:07am, Wednesday, 16'th Aug 2023
Amgen has many blockbuster drugs, including Enbrel, Prolia, and Otezla. Its growth rate hasn't been great recently, but acquisitions could help change that.
Up 970-Fold Since Its IPO, Amgen Stock Could Be Overvalued
10:37am, Monday, 14'th Aug 2023
Amgen's established products declined while some of its best-selling drugs enjoyed growth.
Is Amgen Stock Fully Valued After A 17% Rise In A Month?
09:00am, Monday, 14'th Aug 2023
Amgen stock (NASDAQ: AMGN) has seen a 17% rise in a month, outperforming the broader S&P500 index, up 1%.
These 10 medications are likely targets for Medicare price negotiations this fall
01:22pm, Thursday, 10'th Aug 2023
It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:47am, Thursday, 10'th Aug 2023
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The 3 Best Biotech Stocks to Buy in August
04:00pm, Wednesday, 09'th Aug 2023
Many healthcare stocks suffer from COVID fatigue as profits fall amid a global decline in the virus' spread. But medical innovations and technological breakthroughs are rapidly transforming the health
3 Biotech Stocks You'll Regret Not Buying Soon
11:37pm, Tuesday, 08'th Aug 2023
The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist ( VC ) companies increased investments from 2,200 in 2016 to 3,100 in
Markets Mixed at Midday on New Earnings Reports, Upcoming Data
01:10pm, Monday, 07'th Aug 2023
U.S. equities were mixed at midday on Monday, Aug. 7, 2023, after the latest earnings reports and ahead of key inflation data due later in the week.
Amgen Gives You Growth, Dividend Growth, And Value
08:20am, Monday, 07'th Aug 2023
AMGN has a long track record of top and bottom-line growth, with strong capital returns to shareholders. It recently reported a strong Q2 with a number of drugs seeing double-digit volume and sales gr
Is Growth Priced into Amgen Stock after Earnings Beat?
07:01am, Monday, 07'th Aug 2023
Amgen Inc. NASDAQ: AMGN delivered a solid earnings report after the market closed on August 3. Shareholders hope the results will be enough to reverse the fortunes of AMGN stock, down 12% in 2023.
1 Top Dividend Growth Stock to Buy on the Dip
08:45am, Saturday, 05'th Aug 2023
Amgen faces stiffer competition, adverse exchange rates, and a waning Covid market. But the big biotech should be able to get past these various challenges.
Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised
01:32pm, Friday, 04'th Aug 2023
Amgen (AMGN) beats Q2 estimates for earnings and sales. It slightly raises its earnings and sales guidance for 2023.
Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say
09:01pm, Thursday, 03'rd Aug 2023
While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to W
